Board of Directors
Susan Alesina has more than 25 years of management experience in pharmaceutical, biotech and medical device organizations. Throughout her career, she has had senior roles in strategic planning and analysis, business development and communications. She currently serves as Vice President, National Business Development and Alliances at Boston Children’s Hospital where she leads efforts to identify and develop strategic partnerships with national health systems and hospital providers to improve access for pediatric patients with rare and complex conditions. She is also a board member for the Harvard Business School Healthcare Alumni Association.
Previously, Ms. Alesina was Global Head of Business Partners Communications at Millipore Sigma and prior to that, served as a business consultant for pharmaceutical companies as well as had various leadership roles at Sunovion Pharmaceuticals Inc. in corporate planning, commercial analytics and communications. During her tenure at Sunovion, Ms. Alesina supported the launch of blockbuster products including Lunesta® and Latuda®. Ms. Alesina is a past board member of the Thompson Island Outward Bound Education Center, St. Mark’s School of Southborough, MA, and the Boston Chapter of the Healthcare Businesswomen’s Association, where she was also the president.
Ms. Alesina holds a Bachelor’s degree from the University of North Carolina at Chapel Hill where she was a Morehead-Cain Scholar, and an M.B.A. from Harvard Business School.
-
David Chiswell, Ph.D. – ChairmanFormer CEO, Cambridge Antibody Technology (CAT), Nabriva Therapeutics and Kymab; Currently Chairman, Epsilogen and Board Member of Avillion Bond 2 Development 2 GP
-
Susan AlesinaVice President, National Business Development and Alliances, Boston Children’s Hospital
-
Ron CooperPresident and Chief Executive Officer
-
Habib DableFormer President and CEO, Acceleron Pharma; Currently Independent Director, Blueprint Medicines Corporation, and Venture Partner, RA Capital Management, L.P.
-
Michael Gutch, Ph.D.Chief Financial Officer, Noema Pharma
-
Stephanie S. Okey, M.S.Former Senior Vice President, Head of North America, Rare Diseases, Genzyme, a Sanofi Company
-
Davey S. ScoonFormer CFO, Tom’s of Maine; Board of Trustees, Allianz Global Investors